April 4, 2025
(BBC) – The US couple, aged 37 and 38, ardently believe that the world needs to have more babies or risk civilisational collapse. They have become the poster children for pronatalism, a movement that believes falling birth rates are a … Read More
April 3, 2025
(New York Times) – Orchid screens embryos’ DNA for hundreds of conditions, such as retinitis pigmentosa, which can be traced to a single genetic variant. But the company also goes further, offering what is known as polygenic screening, which gives … Read More
April 3, 2025
The New England Journal of Medicine (vol. 392, no. 10, 2025) is available online by subscription only. Articles include:
March 28, 2025
(Undark) – In an era of open data, genome-wide association studies have become entangled with efforts to prove Black inferiority. Shortly after Abdellaoui announced his withdrawal, he learned that Kirkegaard was scratched from the speaker lineup, and Abdellaoui decided to … Read More
March 28, 2025
(MIT Technology Review) – Stop me if you’ve heard this one before: A tech company accumulates a ton of user data, hoping to figure out a business model later. That business model never arrives, the company goes under, and the … Read More
March 27, 2025
(Wall Street Journal) – He Jiankui stands by a controversial research approach that landed him in prison as he aims to tackle Alzheimer’s disease Chinese scientist He Jiankui set off global outrage and landed in prison after he skirted ethical … Read More
March 26, 2025
(NBC News) – Chinese researchers are reporting new steps in the quest for animal-to-human organ transplants — with a successful pig kidney transplant and a hint Wednesday that pig livers might eventually be useful, too. A Chinese patient is the third person in world … Read More
March 26, 2025
(Wall Street Journal) – Anne Wojcicki aims to buy the assets of her failed DNA-testing company after her prior bids were rejected The company she co-founded, 23andMe, has burned through more than $1 billion and laid off more than half … Read More
March 25, 2025
(Axios) – The demise of 23andMe illustrates the vulnerable state of Americans’ health data, as med tech companies vacuum up more personal information with little regulatory oversight. Why it matters: Fitness trackers, wellness apps, genetic tests and other direct-to-consumer tools … Read More
March 21, 2025
(Nature) – The US National Institutes of Health (NIH) has expanded its cuts to science funding, terminating a growing list of research projects that now encompasses hundreds of grants funding studies on a wide range of topics — from HIV … Read More
March 18, 2025
(Associated Press) – Sarepta Therapeutics said Tuesday that a patient died while taking its closely watched gene therapy for muscular dystrophy, sending company shares plummeting in morning trading. The young man died of acute liver injury, a known side effect, … Read More
March 13, 2025
(Wired) – The mRNA technology behind coronavirus vaccines is now being used to create bespoke vaccines for cancer patients. Lennard Lee, a UK National Health Service oncologist and medical director at the Ellison Institute of Technology in Oxford, calls himself … Read More
March 12, 2025
(Nature) – Researchers have identified 64 genes that help to shape how quickly a person’s brain ages, in one of the largest attempts to pinpoint genetic factors that influence the organ’s decline. The study, published in Science Advances on 12 … Read More
March 12, 2025
(Nature) – After 150,000 articles and 17 million genome sequences, what has science taught us about SARS-CoV-2? Scientists have also generated more than 17 million SARS-CoV-2 genome sequences so far, more than for any other organism. This has given an … Read More
March 12, 2025
(New York Times) – Some scientists are confident that organs from genetically modified pigs will one day be routinely transplanted into humans. But substantial ethical questions remain. They are delivered by C-section to protect them from viruses that sows can … Read More
March 12, 2025
The New England Journal of Medicine (vol. 392, no. 5, 2025) is available online by subscription only. Articles include:
March 12, 2025
European Journal of Human Genetics (vol. 33, no. 2, 2025) is available online by subscription only. Articles include:
March 11, 2025
(Texas Monthly) – Lamm and Shapiro were quick to highlight the utility of the mammouse’s creation. The Colossal Woolly Mouse, though radically cute, is not all that radical from a gene editing perspective. Its creation is not as impactful as, … Read More
March 10, 2025
Bioethics (vol. 39, no. 3, 2025) is available online by subscription only. Articles include:
March 6, 2025
The New England Journal of Medicine (vol. 392, no. 6, 2025) is available online by subscription only. Articles include:
March 5, 2025
(New York Times) – Researchers identified a gene that seems to help slow brain aging in women, and studied links between hormone therapy, menopause and Alzheimer’s. Women’s brains are superior to men’s in at least in one respect — they … Read More
March 5, 2025
(Science) – Risks and benefits of mirror life, AI, synthetic cells debated at anniversary of the landmark 1975 meeting Half a century ago, molecular biologists came together up the hill from the beach in a conference center—made up of exquisite … Read More
March 4, 2025
(NBC News) – Scientists have been genetically engineering mice since the 1970s, but new technologies like CRISPR “make it a lot more efficient and easier.” Extinction is still forever, but scientists at the biotech company Colossal Biosciences are trying what they say … Read More
February 28, 2025
(Wall Street Journal) – Half of all pancreatic cancer patients live less than a year after diagnosis. But researchers say there is potential for change. Researchers estimate by 2030 that deaths will overtake those for colorectal cancer, as other cancers … Read More
February 28, 2025
(Knowable Magazine) – Can genetically modified animals help ease the shortage of organs? After years of research into xenotransplantation, the field is at a turning point — yet risks and ethical issues remain. Over the past few years, a handful … Read More
